Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Short-term Investments: 2009-2016

Historic Short-term Investments for Northwest Biotherapeutics (NWBO) over the last 6 years, with Dec 2016 value amounting to $685,000.

  • Northwest Biotherapeutics' Short-term Investments fell 46.78% to $397,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $397,000, marking a year-over-year decrease of 46.78%. This contributed to the annual value of $685,000 for FY2016, which is 22.69% down from last year.
  • According to the latest figures from FY2016, Northwest Biotherapeutics' Short-term Investments is $685,000, which was down 22.69% from $886,000 recorded in FY2015.
  • In the past 5 years, Northwest Biotherapeutics' Short-term Investments ranged from a high of $886,000 in FY2015 and a low of -$1.0 million during FY2012.
  • Moreover, its 3-year median value for Short-term Investments was $865,000 (2014), whereas its average is $812,000.
  • In the last 5 years, Northwest Biotherapeutics' Short-term Investments increased by 2.43% in 2015 and then dropped by 22.69% in 2016.
  • Over the past 4 years, Northwest Biotherapeutics' Short-term Investments (Yearly) stood at -$1.0 million in 2012, then reached $865,000 in 2014, then increased by 2.43% to $886,000 in 2015, then decreased by 22.69% to $685,000 in 2016.